About the Authors
- Pavan Kumar
-
* E-mail: Pavan_kumar@eisai.com
Affiliation Eisai Inc, Biomarkers and Personalized Medicine Core Function Unit, Eisai Product Creation Systems, Andover, Massachusetts, United States of America
- Zoltan Dezso
-
Affiliation Eisai Inc, Biomarkers and Personalized Medicine Core Function Unit, Eisai Product Creation Systems, Andover, Massachusetts, United States of America
- Crystal MacKenzie
-
Affiliation Eisai Inc, Biomarkers and Personalized Medicine Core Function Unit, Eisai Product Creation Systems, Andover, Massachusetts, United States of America
- Judy Oestreicher
-
Affiliation Eisai Inc, Biomarkers and Personalized Medicine Core Function Unit, Eisai Product Creation Systems, Andover, Massachusetts, United States of America
- Sergei Agoulnik
-
Affiliation Eisai Inc, Biomarkers and Personalized Medicine Core Function Unit, Eisai Product Creation Systems, Andover, Massachusetts, United States of America
- Michael Byrne
-
Affiliation Eisai Inc, Biomarkers and Personalized Medicine Core Function Unit, Eisai Product Creation Systems, Andover, Massachusetts, United States of America
- Francois Bernier
-
Affiliation Eisai Co., Ltd. Biomarkers and Personalized Medicine Core Function Unit, Eisai Product Creation Systems, Tsukuba Research Laboratories, Ibaraki, Japan
- Mamoru Yanagimachi
-
Affiliation Eisai Co., Ltd. Biomarkers and Personalized Medicine Core Function Unit, Eisai Product Creation Systems, Tsukuba Research Laboratories, Ibaraki, Japan
- Ken Aoshima
-
Affiliation Eisai Co., Ltd. Biomarkers and Personalized Medicine Core Function Unit, Eisai Product Creation Systems, Tsukuba Research Laboratories, Ibaraki, Japan
- Yoshiya Oda
-
Affiliation Eisai Inc, Biomarkers and Personalized Medicine Core Function Unit, Eisai Product Creation Systems, Andover, Massachusetts, United States of America
Competing Interests
The authors have the following interests. All authors are employed by Eisai Inc., the funder of this study. This work has resulted in a patent application titled “MicroRNA biomarkers indicative of Alzheimer's Disease”. The patent number is WO2013/003350 A2. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: PK ZD MB FB MY KA YO. Performed the experiments: PK ZD CM JO SA. Analyzed the data: ZD PK KA. Contributed reagents/materials/analysis tools: ZD KA YO. Wrote the paper: PK ZD.